Andrew Guggenhime Vaxcyte, Inc. (PCVX) insider trading activity

PCVX Quotes by TradingView

Andrew Guggenhime is PRESIDENT AND CFO of Vaxcyte, Inc.. Currently has a direct ownership of 131,950 shares of PCVX, which is worth approximately $4.23 Million. The most recent transaction as insider was on Nov 18, 2021, when has been sold 3,100 shares (Common Stock) at a price of $5.35 per share, resulting in proceeds of $16,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K
20.51% 3M change
37.91% 12M change
Total Value Held $4.23 Million

ANDREW GUGGENHIME Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2021
BUY
Exercise of conversion of derivative security
$16,585 $5.35 p/Share
3,100 Added 33.24%
6,225 Common Stock

Also insider at

MTCR
Metacrine, Inc. Healthcare
Director
CRBU
Caribou Biosciences, Inc. Healthcare
Director
AG

Andrew Guggenhime

PRESIDENT AND CFO
San Carlos, CA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCVX